The results collectively suggest that B7-H3 can promote glycolysis in oral squamous cell carcinoma and malignant melanoma, while concurrently inhibiting glycolysis in CD8+ T cells, thereby implying the existence of a glycolysis competition between tumor cells and CD8+ T cells. The gene discussed is CD8A; the disease is melanoma.